The BIO CEO & Investor Conference will be back February 10-11 2014
The aim of the Annual BIO CEO & Investor Conference is to bring together a select group of established public biotech companies and investors to foster the development of important new medicines that will expand the industry’s pipeline. With this mission, companies exclusively developing medical devices or services will not be considered. All final qualifications determined by BIO.
Returning in 2014! Due to its success in 2013, BIO CEO & Investor Conference 2014 will feature a special track with presentations given by private companies. In 2013, 30 private company presentations were scheduled and sold out to standing room only audiences. Presentations in this track will be 13 minutes in length, and will be reserved specifically for established private companies (past Series B round and >$25M raised to date).
Companies that meet the stated criteria should FULLY complete the application form below. Please note, there are registration and presentation fees associated with presenting. Visit our Registration Page for more information.
Only the Company Description and Therapeutic Area of Focus may be used in conference materials. The rest of the information below is used for selection purposes only and will not be printed in conference handbooks, or as profiles for the partnering system.